While GLP-1s are highly effective and drive profound health impacts, low rates of adherence mean employers and health plans are increasingly stuck with rising GLP-1 costs, but without the intended health outcomes and savings
Enov.ones personalized functional health platform gets that effective B12 therapy needs individual assessment and ongoing monitoring instead of cookie-cutter protocols
However, the SUSTAIN six trial evaluated semaglutide, a GLP-1 analog, in patients with type 2 diabetes and high cardiovascular risk and discovered that semaglutide was associated with a higher incidence of diabetic retinopathy complications compared to placebo, with a hazard ratio (HR) of 1.76, particularly in patients with pre-existing DR (Vilsbll et al., 2018)
The wellness weight management program targets the root causes of weight gain, whether hormonal, behavioral, or environmental
J.BaileyS